[Clinical value of determining beta-glucuronidase and glycosaminoglycans in blood cells and biological fluids in patients with rheumatoid arthritis].
Patients with proved rheumatoid arthritis (RA) demonstrated changes in the activity of beta-glucuronidase and the concentration of glycosaminoglycans (GAG) in the blood formed elements and biological fluids showing correlation with peculiarities of the RA course. The content of beta-glucuronidase and GAG in biological fluids well reflected the activity of an inflammatory process. Significant differences in the level of beta-glucuronidase and GAG in blood cells of patients with the articular type of RA and systemic manifestations of disease were revealed.
D000293:Adolescent; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000201:enzymology / Q000378:metabolism*; D001792:Blood Platelets / Q000201:enzymology; D005966:Glucuronidase / Q000097:blood*; D006025:Glycosaminoglycans / Q000097:blood* / Q000652:urine; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology
D006025:Glycosaminoglycans; D005966:Glucuronidase
Klinicheskoe znachenie opredeleniia beta-gliukuronidazy i glikozaminoglikanov v kletkakh krovi i biologicheskikh zhidkostiakh u bol'nykh revmatoidnym artritom.